FDA Office Of Drug Safety Director-Designate Is ODE III Deputy Raczkowski
Executive Summary
FDA Office of Drug Safety Director-designate Victor Raczkowski, MD, brings hands-on experience with the application of risk-management techniques from the review of GlaxoSmithKline's Lotronex
You may also be interested in...
FDA Office Of Drug Safety In Transition; Director Raczkowski Joins Cephalon
Former FDA Office of Drug Safety Director Victor Raczkowski, MD, is joining Cephalon as VP-regulatory affairs
FDA Office Of Drug Safety In Transition; Director Raczkowski Joins Cephalon
Former FDA Office of Drug Safety Director Victor Raczkowski, MD, is joining Cephalon as VP-regulatory affairs
FDA GI Division Director Justice Is Returning To FDA From Genentech
Genentech Senior Clinical Scientist Robert Justice, MD, is returning to FDA as director of the Division of Gastrointestinal & Coagulation Drug Products in September